Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study

J William L Brown, Nick G Cunniffe, Ferran Prados, Baris Kanber, Joanne L Jones, Edward Needham, Zoya Georgieva, David Rog, Owen R Pearson, James Overell, David Macmanus, Rebecca S Samson, Jonathan Stutters, Charles Ffrench-constant, Claudia A M Gandini Wheeler-kingshott, Carla Moran, Paul D Flynn, Andrew W Michell, Robin J M Franklin, Siddharthan ChandranDaniel R Altmann, Declan T Chard, Peter Connick, Alasdair J Coles

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)709-720
JournalThe Lancet Neurology
Issue number9
Publication statusPublished - 1 Sep 2021

Cite this